| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | BlackRock Inc | 7.78M (14.07%) | -86.68K Decreased by -1.11% | Dec 31, 25 |
| 2 | JPMorgan Chase & Co | 7.30M (13.21%) | 730.99K Increased by +10.01% | Sep 30, 25 |
| 3 | Vanguard Group Inc | 6.92M (12.52%) | -359.23K Decreased by -5.19% | Dec 31, 25 |
| 4 | Aristeia Capital, LLC | 5.70M (10.32%) | 2.86M Increased by +50.19% | Dec 31, 25 |
| 5 | Southeastern Asset Management Inc | 3.99M (7.22%) | 1.22M Increased by +30.63% | Dec 31, 25 |
| 6 | Corvex Management LP | 3.36M (6.07%) | 566.70K Increased by +16.89% | Dec 31, 25 |
| 7 | BMO Capital Markets Corp. | 3.13M (5.66%) | 3.12M Increased by +99.77% | Dec 31, 25 |
| 8 | Bank of Montreal | 3.13M (5.66%) | 3.12M Increased by +99.77% | Dec 31, 25 |
| 9 | Davis Selected Advisers | 2.51M (4.55%) | 270.38K Increased by +10.75% | Dec 31, 25 |
| 10 | Burgundy Asset Management Ltd | 2.50M (4.53%) | -15.88K Decreased by -0.63% | Sep 30, 25 |
| 11 | Patients Capital Management LLC | 2.37M (4.30%) | 265.81K Increased by +11.20% | Dec 31, 25 |
| 12 | State Street Corp | 2.19M (3.97%) | -100.37K Decreased by -4.58% | Dec 31, 25 |
| 13 | UBS Asset Mgmt Americas Inc | 2.05M (3.70%) | -801.58K Decreased by -39.18% | Dec 31, 24 |
| 14 | Thompson, Siegel & Walmsley LLC | 1.92M (3.47%) | -67.63K Decreased by -3.52% | Dec 31, 25 |
| 15 | Helikon Investments Ltd | 1.87M (3.38%) | 540.64K Increased by +28.97% | Dec 31, 25 |
| 16 | AQR Capital Management LLC | 1.65M (2.99%) | 502.93K Increased by +30.46% | Dec 31, 25 |
| 17 | Patient Capital Management, LLC | 1.60M (2.89%) | 160.16K Increased by +10.03% | Jun 30, 24 |
| 18 | ShawSpring Partners LLC | 1.49M (2.70%) | -89.85K Decreased by -6.03% | Dec 31, 24 |
| 19 | First Manhattan Co. LLC | 1.34M (2.43%) | -121.30K Decreased by -9.03% | Sep 30, 23 |
| 20 | State Street Corporation | 1.27M (2.29%) | 6.09K Increased by +0.48% | Mar 31, 24 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | UBS: Global Equity | 8.93M (16.15%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 2 | iShares Core S&P Small-Cap ETF | 3.97M (7.19%) | 5.55K Increased by +0.14% | Apr 29, 26 |
| 3 | JPMorgan Mid Cap Value L | 2.78M (5.04%) | 53.91K Increased by +1.94% | Jul 31, 25 |
| 4 | JPM US Mid Cap Value-Composite | 2.73M (4.94%) | 639.09K Increased by +23.41% | Jun 30, 25 |
| 5 | Vanguard US Total Market Shares ETF | 2.25M (4.07%) | 2.52K Increased by +0.11% | Sep 30, 24 |
| 6 | JPM US Mid Cap Value-MA | 2.09M (3.78%) | 139.95K Increased by +6.69% | Mar 31, 25 |
| 7 | Longleaf Partners | 2.07M (3.74%) | 128.19K Increased by +6.20% | Mar 31, 26 |
| 8 | Vanguard Total Stock Mkt Idx Inv | 2.06M (3.72%) | 19.27K Increased by +0.94% | Mar 31, 26 |
| 9 | Patient Opportunity C | 1.80M (3.26%) | 0.00 Increased by 0.00% | Mar 31, 26 |
| 10 | Vanguard Small Cap Index | 1.48M (2.67%) | 12.88K Increased by +0.87% | Mar 31, 26 |
| 11 | Longleaf Partners Global | 1.31M (2.37%) | -88.96K Decreased by -6.79% | Mar 31, 26 |
| 12 | Davis NY Venture A | 1.13M (2.04%) | 0.00 Increased by 0.00% | Jan 31, 26 |
| 13 | JPM US Value Advantage-MA | 1.07M (1.93%) | 1.02M Increased by +95.55% | Sep 30, 23 |
| 14 | Contrarius Global Equity Institutional | 1.02M (1.85%) | 1.02M Increased by +100.00% | Mar 31, 25 |
| 15 | JPMorgan Value Advantage L | 990.55K (1.79%) | 0.00 Increased by 0.00% | Jul 31, 25 |
| 16 | AVI Global Trust Ord | 985.00K (1.78%) | 0.00 Increased by 0.00% | Feb 28, 25 |
| 17 | Vanguard Small Cap Value Index Inv | 940.38K (1.70%) | -146.00 Decreased by -0.02% | Mar 31, 26 |
| 18 | JPMorgan Mid Cap Equity I | 905.60K (1.64%) | 134.93K Increased by +14.90% | Jul 31, 25 |
| 19 | Vanguard Institutional Extnd Mkt Idx Tr | 726.30K (1.31%) | 15.48K Increased by +2.13% | Mar 31, 26 |
| 20 | Vanguard Explorer Inv | 680.41K (1.23%) | -248.07K Decreased by -36.46% | Jun 30, 25 |